RxDoctor Payments DataLook up a doctor →

Jordan Tate

Interventional Pain Medicine · Jasper, GANPI 1508008079

Payments from drug & device makers

$763,569in general payments, 2019–2025

Across 1,343 payments — averaging $568.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$250K
  • Curonix LLC$106K
  • Nalu Medical, Inc.$99K
  • Saluda Medical Americas, Inc.$93K
  • Stryker$45K
  • Medtronic$40K
  • plus $130K from 48 others
$3,425in research payments, 2019–2025

Across 4 payments — averaging $856.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Saluda Medical Americas, Inc.$3K
  • Medtronic$820

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$763,569 in reported general payments places this provider in the 95th percentile of 129 interventional pain medicine providers in Georgia.

See all interventional pain medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$273,498
Medicare patients
388
Services billed
3,063

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Jasper

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →